Literature DB >> 34373896

Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.

Amelia Strom1, Leonardo Iaccarino1, Lauren Edwards1, Orit H Lesman-Segev1,2, David N Soleimani-Meigooni1, Julie Pham1, Suzanne L Baker3, Susan M Landau4, William J Jagust3,4, Bruce L Miller1, Howard J Rosen1, Maria Luisa Gorno-Tempini1, Gil D Rabinovici1,3,4,5, Renaud La Joie1.   

Abstract

Posterior cortical hypometabolism measured with 18F-fluorodeoxyglucose (FDG)-PET is a well-known marker of Alzheimer's disease-related neurodegeneration, but its associations with underlying neuropathological processes are unclear. We assessed cross-sectionally the relative contributions of three potential mechanisms causing hypometabolism in the retrosplenial and inferior parietal cortices: local molecular (amyloid and tau) pathology and atrophy, distant factors including contributions from the degenerating medial temporal lobe or molecular pathology in functionally connected regions, and the presence of the apolipoprotein E (APOE) ε4 allele. Two hundred and thirty-two amyloid-positive cognitively impaired patients from two cohorts [University of California, San Francisco (UCSF), and Alzheimer's Disease Neuroimaging Initiative (ADNI)] underwent MRI and PET with FDG, amyloid-PET using 11C-Pittsburgh Compound-B, 18F-florbetapir or 18F-florbetaben, and 18F-flortaucipir tau-PET in 1 year. Standard uptake value ratios (SUVRs) were calculated using tracer-specific reference regions. Regression analyses were run within cohorts to identify variables associated with retrosplenial or inferior parietal FDG standard uptake value ratios. On average, ADNI patients were older and were less impaired than the UCSF patients. Regional patterns of hypometabolism were similar between cohorts, although there were cohort differences in regional grey matter atrophy. Local cortical thickness and tau-PET (but not amyloid-PET) were independently associated with both retrosplenial and inferior parietal FDG SUVRs (ΔR2 = 0.09 to 0.21) across cohorts in models that also included age and disease severity (local model). Including medial temporal lobe volume improved the retrosplenial FDG model in the ADNI cohort (ΔR2 = 0.04, P = 0.008) but not for the UCSF (ΔR2 < 0.01, P = 0.52), and did not improve the inferior parietal models (ΔR2 < 0.01, P > 0.37). Interaction analyses revealed that medial temporal volume was more strongly associated with retrosplenial FDG SUVRs at earlier disease stages (P = 0.06 in UCSF, P = 0.046 in ADNI). Exploratory analyses across the cortex confirmed overall associations between hypometabolism and local tau pathology and thickness and revealed associations between medial temporal degeneration and hypometabolism in retrosplenial, orbitofrontal and anterior cingulate cortices. Finally, our data did not support hypotheses of a detrimental effect of pathology in connected regions or of an effect of the APOE ε4 allele in impaired participants. Overall, in two independent groups of patients at symptomatic stages of Alzheimer's disease, cortical hypometabolism mainly reflected structural neurodegeneration and tau, but not amyloid, pathology.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; PET; amyloid; hypometabolism; tau

Mesh:

Substances:

Year:  2022        PMID: 34373896      PMCID: PMC9014741          DOI: 10.1093/brain/awab294

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   15.255


  108 in total

1.  "Crossed cerebellar diaschisis" in human supratentorial brain infarction.

Authors:  J C Baron; M G Bousser; D Comar; P Castaigne
Journal:  Trans Am Neurol Assoc       Date:  1981

2.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

Authors:  S Minoshima; B Giordani; S Berent; K A Frey; N L Foster; D E Kuhl
Journal:  Ann Neurol       Date:  1997-07       Impact factor: 10.422

3.  Predicting regional neurodegeneration from the healthy brain functional connectome.

Authors:  Juan Zhou; Efstathios D Gennatas; Joel H Kramer; Bruce L Miller; William W Seeley
Journal:  Neuron       Date:  2012-03-21       Impact factor: 17.173

4.  Brain metabolic signatures across the Alzheimer's disease spectrum.

Authors:  Arianna Sala; Camilla Caprioglio; Roberto Santangelo; Emilia Giovanna Vanoli; Sandro Iannaccone; Giuseppe Magnani; Daniela Perani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-07       Impact factor: 9.236

5.  Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET.

Authors:  Renaud La Joie; Adrienne V Visani; Suzanne L Baker; Jesse A Brown; Viktoriya Bourakova; Jungho Cha; Kiran Chaudhary; Lauren Edwards; Leonardo Iaccarino; Mustafa Janabi; Orit H Lesman-Segev; Zachary A Miller; David C Perry; James P O'Neil; Julie Pham; Julio C Rojas; Howard J Rosen; William W Seeley; Richard M Tsai; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Sci Transl Med       Date:  2020-01-01       Impact factor: 17.956

6.  Positron emission tomography in the study of aging and senile dementia.

Authors:  S H Ferris; M J de Leon; A P Wolf; T Farkas; D R Christman; B Reisberg; J S Fowler; R Macgregor; A Goldman; A E George; S Rampal
Journal:  Neurobiol Aging       Date:  1980       Impact factor: 4.673

7.  18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.

Authors:  Niklas Mattsson; Michael Schöll; Olof Strandberg; Ruben Smith; Sebastian Palmqvist; Philip S Insel; Douglas Hägerström; Tomas Ohlsson; Henrik Zetterberg; Jonas Jögi; Kaj Blennow; Oskar Hansson
Journal:  EMBO Mol Med       Date:  2017-09       Impact factor: 12.137

Review 8.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

Review 9.  The cingulum bundle: Anatomy, function, and dysfunction.

Authors:  Emma J Bubb; Claudia Metzler-Baddeley; John P Aggleton
Journal:  Neurosci Biobehav Rev       Date:  2018-05-16       Impact factor: 8.989

10.  Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.

Authors:  Una Smailovic; Thomas Koenig; Irina Savitcheva; Konstantinos Chiotis; Agneta Nordberg; Kaj Blennow; Bengt Winblad; Vesna Jelic
Journal:  Brain Connect       Date:  2020-11-23
View more
  3 in total

1.  Causal links among amyloid, tau, and neurodegeneration.

Authors:  Murat Bilgel; Dean F Wong; Abhay R Moghekar; Luigi Ferrucci; Susan M Resnick
Journal:  Brain Commun       Date:  2022-07-25

Review 2.  Brain Glucose Hypometabolism and Iron Accumulation in Different Brain Regions in Alzheimer's and Parkinson's Diseases.

Authors:  Indira Y Rao; Leah R Hanson; Julia C Johnson; Michael H Rosenbloom; William H Frey
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-29

3.  Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign.

Authors:  Kennedy A Josephs; Nha Trang Thu Pham; Jonathan Graff-Radford; Mary M Machulda; Val J Lowe; Jennifer L Whitwell
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.